0 Ratings
ID

32241

Description

The Effect of Ketamine on Attentiveness; ODM derived from: https://clinicaltrials.gov/show/NCT01165294

Link

https://clinicaltrials.gov/show/NCT01165294

Keywords

Versions (3)
  1. 10/24/18 10/24/18 -
  2. 10/24/18 10/24/18 -
  3. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

October 24, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Schizophrenia NCT01165294

    English

    Eligibility Schizophrenia NCT01165294

    1 forms  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    normal ecg and safety assessments, or minor no-relevant deviations, at screening
    Description

    ECG normal | Safety Assessment Normal

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0522054
    UMLS CUI [2,1]
    C0549076
    UMLS CUI [2,2]
    C0205307
    vital signs: systolic between 100 and 140 mmhg and diastolic between 50 and 90 mmhg and heart rate between 45 and 90 beats/min
    Description

    Vital signs | Systolic Pressure | Diastolic blood pressure | Heart rate

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0518766
    UMLS CUI [2]
    C0871470
    UMLS CUI [3]
    C0428883
    UMLS CUI [4]
    C0018810
    no medication intake in the last four weeks
    Description

    Pharmaceutical Preparations Intake Absent

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C1512806
    UMLS CUI [1,3]
    C0332197
    volunteers must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study and to adhere to the prohibitions and restrictions specified in the protocol
    Description

    Informed Consent | Protocol Compliance

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    UMLS CUI [2]
    C0525058
    negative drug screen
    Description

    Drug screen negative

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0919819
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    participation in another clinical trial in the last 3 months
    Description

    Study Subject Participation Status

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    significant allergies, allergic diathesis or known hypersensitivity for ketamine or its ingredients (ie, benzethonium chloride)
    Description

    Hypersensitivity | Diathesis allergic | Ketamine allergy | Hypersensitivity Ketamine Ingredient | Hypersensitivity Benzethonium Chloride

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0020517
    UMLS CUI [2,1]
    C0012655
    UMLS CUI [2,2]
    C0700624
    UMLS CUI [3]
    C0570631
    UMLS CUI [4,1]
    C0020517
    UMLS CUI [4,2]
    C0022614
    UMLS CUI [4,3]
    C1550600
    UMLS CUI [5,1]
    C0020517
    UMLS CUI [5,2]
    C0079015
    history of or current significant respiratory disease, cardiovascular disease, endocrinological, gastrointestinal, neurological, glaucoma and known liver and kidney failure
    Description

    Respiration Disorder | Cardiovascular Disease | Endocrine System Diseases | Gastrointestinal Disease | Nervous system disorder | Glaucoma | Liver Failure | Kidney Failure

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0035204
    UMLS CUI [2]
    C0007222
    UMLS CUI [3]
    C0014130
    UMLS CUI [4]
    C0017178
    UMLS CUI [5]
    C0027765
    UMLS CUI [6]
    C0017601
    UMLS CUI [7]
    C0085605
    UMLS CUI [8]
    C0035078
    contraindications for an mri being performed (claustrophobia, metal parts, pacemaker)
    Description

    Medical contraindication MRI | Claustrophobia | Parts Metallic | Artificial cardiac pacemaker

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1301624
    UMLS CUI [1,2]
    C0024485
    UMLS CUI [2]
    C0008909
    UMLS CUI [3,1]
    C0449719
    UMLS CUI [3,2]
    C2986473
    UMLS CUI [4]
    C0030163
    oxygen saturation po2 < 90 mmhg
    Description

    Oxygen saturation measurement | PO2 measurement

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0523807
    UMLS CUI [2]
    C1283004
    clinically significant abnormalities in ecg or laboratory values
    Description

    ECG abnormality | Laboratory test result abnormal

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1832603
    UMLS CUI [2]
    C0438215
    recent history (within previous 6 months) of alcohol or drug abuse
    Description

    Substance Use Disorders

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0038586
    history of or current psychiatric diagnoses (dsm-iv, ii) or neurological disorders
    Description

    Mental disorders | Nervous system disorder

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0004936
    UMLS CUI [2]
    C0027765
    relatives in first or second degree with a schizophrenic disorder
    Description

    Schizophrenia First Degree Relative | Schizophrenia Second Degree Relative

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0036341
    UMLS CUI [1,2]
    C1517194
    UMLS CUI [2,1]
    C0036341
    UMLS CUI [2,2]
    C1519210
    serology positive for hepatitis b surface antigen, hepatitis c antibodies or hiv antibodies
    Description

    Serology positive Hepatitis B Surface Antigens | Serology positive Hepatitis C Antibodies | Serology positive HIV Antibodies

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0242089
    UMLS CUI [1,2]
    C0019168
    UMLS CUI [2,1]
    C0242089
    UMLS CUI [2,2]
    C0166049
    UMLS CUI [3,1]
    C0242089
    UMLS CUI [3,2]
    C0019683
    signs of hyperthyroidism based on the determination of t3, t4 and tsh
    Description

    Signs Hyperthyroidism | Triiodothyronine measurement | Thyroxine measurement | Thyroid stimulating hormone measurement

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0311392
    UMLS CUI [1,2]
    C0020550
    UMLS CUI [2]
    C0428419
    UMLS CUI [3]
    C0202231
    UMLS CUI [4]
    C0202230
    Back to the top of the page

    Similar models

    Eligibility Schizophrenia NCT01165294

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ECG normal | Safety Assessment Normal
    Item
    normal ecg and safety assessments, or minor no-relevant deviations, at screening
    boolean
    C0522054 (UMLS CUI [1])
    C0549076 (UMLS CUI [2,1])
    C0205307 (UMLS CUI [2,2])
    Vital signs | Systolic Pressure | Diastolic blood pressure | Heart rate
    Item
    vital signs: systolic between 100 and 140 mmhg and diastolic between 50 and 90 mmhg and heart rate between 45 and 90 beats/min
    boolean
    C0518766 (UMLS CUI [1])
    C0871470 (UMLS CUI [2])
    C0428883 (UMLS CUI [3])
    C0018810 (UMLS CUI [4])
    Pharmaceutical Preparations Intake Absent
    Item
    no medication intake in the last four weeks
    boolean
    C0013227 (UMLS CUI [1,1])
    C1512806 (UMLS CUI [1,2])
    C0332197 (UMLS CUI [1,3])
    Informed Consent | Protocol Compliance
    Item
    volunteers must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study and to adhere to the prohibitions and restrictions specified in the protocol
    boolean
    C0021430 (UMLS CUI [1])
    C0525058 (UMLS CUI [2])
    Drug screen negative
    Item
    negative drug screen
    boolean
    C0919819 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Study Subject Participation Status
    Item
    participation in another clinical trial in the last 3 months
    boolean
    C2348568 (UMLS CUI [1])
    Hypersensitivity | Diathesis allergic | Ketamine allergy | Hypersensitivity Ketamine Ingredient | Hypersensitivity Benzethonium Chloride
    Item
    significant allergies, allergic diathesis or known hypersensitivity for ketamine or its ingredients (ie, benzethonium chloride)
    boolean
    C0020517 (UMLS CUI [1])
    C0012655 (UMLS CUI [2,1])
    C0700624 (UMLS CUI [2,2])
    C0570631 (UMLS CUI [3])
    C0020517 (UMLS CUI [4,1])
    C0022614 (UMLS CUI [4,2])
    C1550600 (UMLS CUI [4,3])
    C0020517 (UMLS CUI [5,1])
    C0079015 (UMLS CUI [5,2])
    Respiration Disorder | Cardiovascular Disease | Endocrine System Diseases | Gastrointestinal Disease | Nervous system disorder | Glaucoma | Liver Failure | Kidney Failure
    Item
    history of or current significant respiratory disease, cardiovascular disease, endocrinological, gastrointestinal, neurological, glaucoma and known liver and kidney failure
    boolean
    C0035204 (UMLS CUI [1])
    C0007222 (UMLS CUI [2])
    C0014130 (UMLS CUI [3])
    C0017178 (UMLS CUI [4])
    C0027765 (UMLS CUI [5])
    C0017601 (UMLS CUI [6])
    C0085605 (UMLS CUI [7])
    C0035078 (UMLS CUI [8])
    Medical contraindication MRI | Claustrophobia | Parts Metallic | Artificial cardiac pacemaker
    Item
    contraindications for an mri being performed (claustrophobia, metal parts, pacemaker)
    boolean
    C1301624 (UMLS CUI [1,1])
    C0024485 (UMLS CUI [1,2])
    C0008909 (UMLS CUI [2])
    C0449719 (UMLS CUI [3,1])
    C2986473 (UMLS CUI [3,2])
    C0030163 (UMLS CUI [4])
    Oxygen saturation measurement | PO2 measurement
    Item
    oxygen saturation po2 < 90 mmhg
    boolean
    C0523807 (UMLS CUI [1])
    C1283004 (UMLS CUI [2])
    ECG abnormality | Laboratory test result abnormal
    Item
    clinically significant abnormalities in ecg or laboratory values
    boolean
    C1832603 (UMLS CUI [1])
    C0438215 (UMLS CUI [2])
    Substance Use Disorders
    Item
    recent history (within previous 6 months) of alcohol or drug abuse
    boolean
    C0038586 (UMLS CUI [1])
    Mental disorders | Nervous system disorder
    Item
    history of or current psychiatric diagnoses (dsm-iv, ii) or neurological disorders
    boolean
    C0004936 (UMLS CUI [1])
    C0027765 (UMLS CUI [2])
    Schizophrenia First Degree Relative | Schizophrenia Second Degree Relative
    Item
    relatives in first or second degree with a schizophrenic disorder
    boolean
    C0036341 (UMLS CUI [1,1])
    C1517194 (UMLS CUI [1,2])
    C0036341 (UMLS CUI [2,1])
    C1519210 (UMLS CUI [2,2])
    Serology positive Hepatitis B Surface Antigens | Serology positive Hepatitis C Antibodies | Serology positive HIV Antibodies
    Item
    serology positive for hepatitis b surface antigen, hepatitis c antibodies or hiv antibodies
    boolean
    C0242089 (UMLS CUI [1,1])
    C0019168 (UMLS CUI [1,2])
    C0242089 (UMLS CUI [2,1])
    C0166049 (UMLS CUI [2,2])
    C0242089 (UMLS CUI [3,1])
    C0019683 (UMLS CUI [3,2])
    Signs Hyperthyroidism | Triiodothyronine measurement | Thyroxine measurement | Thyroid stimulating hormone measurement
    Item
    signs of hyperthyroidism based on the determination of t3, t4 and tsh
    boolean
    C0311392 (UMLS CUI [1,1])
    C0020550 (UMLS CUI [1,2])
    C0428419 (UMLS CUI [2])
    C0202231 (UMLS CUI [3])
    C0202230 (UMLS CUI [4])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial